Rani Therapeutics Holdings RANI
NASDAQ RANI
$0.81 +0.01 (+1.25%)
At close: Oct 2, 2026 · 4:00 PM EDT

Rani Therapeutics Holdings (RANI) Interest & Investment Income (2020 - 2026)

Updated

Rani Therapeutics Holdings (RANI) posted Interest & Investment Income of $415,000 for Q2 2026, up 162.7% from $158,000 a year earlier and up 0.7% from the prior quarter.

Analysis

Rani Therapeutics Holdings (RANI) Interest & Investment Income (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Interest & Investment Income at Rani Therapeutics Holdings was $1.28 million, up 11.2% year-over-year; for FY2025, it came in at $827,000, down 53.1% from FY2024.

  • Annual Interest & Investment Income shows a five-year compound annual growth rate of 67.4% (FY2020 to FY2025).
  • In prior years, Rani Therapeutics Holdings' Interest & Investment Income was $1.76 million in FY2024 (-46.6%), $3.3 million in FY2023 (+164.5%), $1.25 million in FY2022 and $89,000 in FY2021 (+41.3%).
  • The Q2 2026 figure stands as the highest quarterly Interest & Investment Income since Q2 2024.
  • On a year-over-year basis, Interest & Investment Income has increased in each of the last three quarters, with an average decline of 5.9% over the last eight quarters.
  • The strongest year-over-year quarter for Interest & Investment Income in the past five years was Q2 2022, with growth of 169.2%; the weakest was Q3 2025, with a decline of 83.6%.
  • According to Business Quant data, Interest & Investment Income for the three prior quarters was $412,000 (Q1 2026), $384,000 (Q4 2025) and $68,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Rani Therapeutics Holdings 151.61 Mn 160.36 Mn - 415,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 415,000.00
Mar 31, 2026 412,000.00
Dec 31, 2025 384,000.00
Sep 30, 2025 68,000.00
Jun 30, 2025 158,000.00
Mar 31, 2025 218,000.00
Dec 31, 2024 360,000.00
Sep 30, 2024 414,000.00
Jun 30, 2024 439,000.00
Mar 31, 2024 549,000.00
Dec 31, 2023 675,000.00
Sep 30, 2023 839,000.00
Jun 30, 2023 896,000.00
Mar 31, 2023 891,000.00
Dec 31, 2022 818,000.00
Sep 30, 2022 379,000.00
Jun 30, 2022 35,000.00
Mar 31, 2022 15,000.00
Dec 31, 2021 16,000.00
Sep 30, 2021 13,000.00
API Access

Rani Therapeutics Holdings Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=RANI&period=max&api_key=YOUR_API_KEY